Are there potential problems with generic substitution of antiepileptic drugs?, Seizure, vol.15, issue.3, pp.165-76, 2006. ,
DOI : 10.1016/j.seizure.2005.12.010
Generic antiepileptic drugs and increased health care utilization: Fact or myth?, Neurology, vol.74, issue.20, pp.1562-1565, 2010. ,
DOI : 10.1212/WNL.0b013e3181e1d4b4
Antiepileptic drugs: generic versus branded treatments, The Lancet Neurology, vol.6, issue.5, pp.465-473, 2007. ,
DOI : 10.1016/S1474-4422(07)70105-9
Generic Products of Antiepileptic Drugs (AEDs): Is It an Issue?, Epilepsia, vol.30, issue.10, pp.1825-1857, 2007. ,
DOI : 10.1016/j.yebeh.2004.05.011
Current approaches to the use of generic antiepileptic drugs, Epilepsy & Behavior, vol.11, issue.1, pp.46-52, 2007. ,
DOI : 10.1016/j.yebeh.2007.03.014
Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy, Neurology, vol.68, issue.16, pp.1249-50, 2007. ,
DOI : 10.1212/01.wnl.0000259400.30539.cc
Recommendations of the Italian League Against Epilepsy Working Group on Generic Products of Antiepileptic Drugs, Epilepsia, vol.26, issue.5, pp.16-20, 2006. ,
DOI : 10.1001/jama.258.9.1216
Utilisation des m??dicaments g??n??riques des anti-??pileptiques en France : r??sultats d???une enqu??te aupr??s des neurologues et revue de la litt??rature, Revue Neurologique, vol.163, issue.4, pp.455-61, 2007. ,
DOI : 10.1016/S0035-3787(07)90421-X
Generic substitution in the treatment of epilepsy: Patient and physician perceptions, Epilepsy & Behavior, vol.13, issue.4, pp.693-702, 2008. ,
DOI : 10.1016/j.yebeh.2008.06.001
Generic substitution of antiepileptic drugs ??? A survey of patients' perspectives in Germany and other German-speaking countries, Epilepsy & Behavior, vol.27, issue.1, pp.135-144, 2013. ,
DOI : 10.1016/j.yebeh.2012.12.029
Generic substitution in the treatment of epilepsy: Patient attitudes and perceptions, Epilepsy & Behavior, vol.26, issue.1, pp.64-70, 2013. ,
DOI : 10.1016/j.yebeh.2012.10.032
Compulsory Generic Switching of Antiepileptic Drugs: High Switchback Rates to Branded Compounds Compared with Other Drug Classes, Epilepsia, vol.26, issue.3, pp.464-473, 2007. ,
DOI : 10.1001/jama.258.9.1216
Clinical consequences of generic substitution of lamotrigine for patients with epilepsy, Neurology, vol.70, issue.Issue 22, Part 2, pp.2179-86, 2008. ,
DOI : 10.1212/01.wnl.0000313154.55518.25
The risks and costs of multiple-generic substitution of topiramate, Neurology, vol.72, issue.24, pp.2122-2131, 2009. ,
DOI : 10.1212/WNL.0b013e3181aa5300
Generic antiepileptic drugs and associated medical resource utilization in the United States, Neurology, vol.74, issue.20, pp.1566-74, 2010. ,
DOI : 10.1212/WNL.0b013e3181df091b
Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes, Epilepsia, vol.5, issue.Suppl 5, pp.493-500, 2009. ,
DOI : 10.1111/j.1528-1167.2008.01703.x
Association between antiepileptic drug switching and epilepsy-related events, Epilepsy & Behavior, vol.15, issue.4, pp.481-486, 2009. ,
DOI : 10.1016/j.yebeh.2009.05.019
Effects of Antiepileptic Drug Substitutions on Epileptic Events Requiring Acute Care, Pharmacotherapy, vol.41, issue.7, pp.769-74, 2009. ,
DOI : 10.1111/j.1528-1167.2008.01703.x
Seizure Outcomes Following the Use of Generic versus Brand-Name Antiepileptic Drugs, Drugs, vol.14, issue.1, pp.605-626, 2010. ,
DOI : 10.2165/10898530-000000000-00000
Clinical and pharmacy utilization outcomes with brand to generic antiepileptic switches in patients with epilepsy, Epilepsia, vol.50, issue.7, pp.1365-71, 2011. ,
DOI : 10.1111/j.1528-1167.2011.03130.x
Factors Associated with Seizure Recurrence in Epilepsy Patients Treated with Antiepileptic Monotherapy: A Retrospective Observational Cohort Study using US Administrative Insurance Claims, CNS Drugs, vol.58, issue.1???2, pp.1047-58, 2014. ,
DOI : 10.1007/s40263-014-0191-1
Acute epilepsy exacerbations in patients switched between A-rated anti-epileptic drugs, Current Medical Research and Opinion, vol.26, issue.2, pp.455-63, 2010. ,
DOI : 10.1185/03007990903488704
Bioequivalent antiepileptic drug switching and the risk of seizure-related events, Epilepsy Research, vol.106, issue.1-2, pp.237-280, 2013. ,
DOI : 10.1016/j.eplepsyres.2013.04.010